tiprankstipranks
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
Holding NRXP?
Track your performance easily

NRX Pharmaceuticals (NRXP) Financial Statements

324 Followers

NRX Pharmaceuticals Financial Overview

NRX Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.153; its P/E ratio is -0.56; NRX Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.62M$ -7.90M$ -5.98M$ -4.25M$ -8.72M
EBITDA$ -1.62M$ -7.90M$ -5.98M$ -4.25M$ -8.72M
Net Income Common Stockholders$ -1.62M$ -7.90M$ -6.53M$ -4.34M$ -8.72M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.65M$ 1.90M$ 1.32M$ 4.59M$ 14.97M
Total Assets$ 4.46M$ 5.26M$ 3.79M$ 7.32M$ 19.81M
Total Debt$ 6.67M$ 8.59M$ 0.00$ 0.00$ 0.00
Net Debt$ 5.02M$ 6.70M$ -1.32M$ -4.59M$ -14.97M
Total Liabilities$ 23.28M$ 23.66M$ 18.86M$ 19.05M$ 22.62M
Stockholders Equity$ -18.82M$ -18.39M$ -15.07M$ -11.73M$ -2.81M
Cash Flow-
Free Cash Flow$ -2.31M$ -2.56M$ -3.67M$ -3.19M$ -7.81M
Operating Cash Flow$ -2.31M$ -2.56M$ -3.67M$ -3.19M$ -7.81M
Investing Cash Flow---$ 1.00K$ 2.00K
Financing Cash Flow$ 2.05M$ 3.14M$ 395.00K$ -1.12M$ 6.27M
Currency in USD

NRX Pharmaceuticals Earnings and Revenue History

NRX Pharmaceuticals Debt to Assets

NRX Pharmaceuticals Cash Flow

NRX Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis